BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,505 | +48.4% | 212,698 | +47.6% | 0.02% | +66.7% |
| Q2 2023 | $1,014 | +95.8% | 144,062 | +131.5% | 0.01% | +50.0% |
| Q1 2023 | $518 | -99.8% | 62,223 | +161.4% | 0.01% | +100.0% |
| Q3 2022 | $299,000 | -83.5% | 23,803 | -81.1% | 0.00% | -72.7% |
| Q3 2021 | $1,812,000 | -3.3% | 126,125 | +6.4% | 0.01% | -35.3% |
| Q2 2021 | $1,874,000 | +362.7% | 118,550 | +197.6% | 0.02% | +325.0% |
| Q1 2021 | $405,000 | -82.0% | 39,830 | -86.8% | 0.00% | -91.1% |
| Q4 2020 | $2,247,000 | +916.7% | 301,682 | +289.6% | 0.04% | +350.0% |
| Q3 2019 | $221,000 | +35.6% | 77,424 | +605.6% | 0.01% | -87.0% |
| Q2 2015 | $163,000 | – | 10,973 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |